Professional Documents
Culture Documents
Name of Patient: _Patient MJ___________ Date of Admission: _November 8, 2021 @8:00AM Room: __P302_
Age: _27 months old_ Sex: _Male_ Civil Status: _N/A_ Chief Complaint: 2nd degree burn
Religion: ___N/A___________ Attending Physician: ___Dr. Lariosa____
Edelyn Santoyo
Name of Student
DRUG STUDY
Medication Mode of Action Dosage Indication(s) Contraindication(s) Side Effects Adverse Effects Nurses Responsibilities
Generic Name: The vaccine 0.5mL IM 4th Provide - Patients who have had CNS: CNS: Be prepared for life
Dtap vaccine produces an dose protection a severe allergic Feeling Fussiness, threating reaction
active immune (immunity) reaction (e.g., tired seizures, high when ever
Brand Name: response of the against anaphylaxis) after a fever immunizing children.
Adacel body by diphtheria, previous dose At every
developing tetanus -Hypersensitivity to any Injection visit/encounter child’s
Classification: antibodies and (lockjaw), and of the vaccine site: immunization record
Soreness, GI:
antitoxins against pertussis components Loss of appetite, should be reviewed.
the toxoids and (whooping redness, Review child’s
swelling, vomiting
acellular pertussis cough) in allergies (food and
antigens children pain medicine).
between 6 Review potential
weeks and 7 contraindications to
years old. each vaccine.
Review past
immunization history
for past reactions.
Assess child for
anxiety and fear
related to
administration.
Obtain informed
consent.
Use the same brand
whenever possible.
Inform parents of
increased risk of
reaction to dose 4 &
5.
Instruct parents to
report and bring child
to hospital if any
adverse effects
occurred.
If child had a serious
adverse reaction to
any previous dose,
the next doses should
be deferred.
Give parent current
VIS (vaccine
information
statement) in
REFERENCES:
CDC. (August 6, 2021). DTaP (Diphtheria, Tetanus, Pertussis) Vaccine: What you need to know. https://www.cdc.gov/vaccines/hcp/vis/vis-statements/dtap.html
Weaver, B. (2014). Vaccines and Vaccine Preventable Communicable Illness of Childhood. https://slideplayer.com/slide/5884445/
FDAR:
R After 8 hours
Patient pain was relieved. Wong Baker face pain scale 0/10, no
irritability, and crying noted. Wound care is continued.
CUS:
Collaboration:
C I am concerned that the mother had to bring her child her despite not
knowing what was chewed by the child.
Ethico-Moral-Legal Consideration: